2013
DOI: 10.1016/j.bbi.2012.10.015
|View full text |Cite
|
Sign up to set email alerts
|

Placenta-derived adherent cells attenuate hyperalgesia and neuroinflammatory response associated with perineural inflammation in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

5
4

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 33 publications
0
21
0
Order By: Relevance
“…[7][8][9]13 In the current study, we explored the angiogenic properties of PDACs. In vitro, PDACs exhibited various activities consistent with angiogenesis, including enhancement of endothelial cell survival under conditions of serum starvation and stimulation of tube formation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[7][8][9]13 In the current study, we explored the angiogenic properties of PDACs. In vitro, PDACs exhibited various activities consistent with angiogenesis, including enhancement of endothelial cell survival under conditions of serum starvation and stimulation of tube formation.…”
Section: Discussionmentioning
confidence: 99%
“…The cells are anchorage dependent in culture and adhere to plastic during expansion in vitro. 7 PDAC-mediated activities have been studied in vitro, in animal models, and in clinical trials and display immunomodulatory, anti-inflammatory, proregenerative, and neuroprotective properties, [7][8][9][10] suggesting that the cells may have potential utility across a variety of disease indications. PDA-002, an intramuscular formulation of PDACs, is in clinical development for the treatment of peripheral arterial disease with diabetic foot ulcer (http:// clinicaltrials.gov/show/NCT01859117).…”
mentioning
confidence: 99%
“…Placenta-Derived Adherent Cells (PDAC®) are mesenchymal stromal-like cells isolated from human placental tissue and culture-expanded [13][15]. PDAC® display the nominal phenotype CD34−, CD10+, CD200+, and CD105+ [16].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, in the ipsilateral sciatic nerve, significantly less leukocyte infiltration was observed in PDA-001-treated animals. The results suggest that PDA-001 may provide a novel therapeutic approach in the management of inflammatory neuropathic pain and similar conditions [29] .…”
Section: Metastin and Stem Cells From Human Placentamentioning
confidence: 98%